Biotech Beach Bum

Cash continues to flow to good biotech firms, three listed here. Of these, Auspex’s deuterium modification project – replacing strategic hydrogen molecules in a drug with deuterium to slow liver metabolism and excretion – looks particularly interesting, with the potential for far-reaching changes to the way small molecules are used and marketed as pharmaceuticals.

 http://www.xconomy.com/san-diego/2009/08/19/san-diego-biotech-startups-raise-new-cash-to-treat-anemia-heart-disease-and-more/